The MassARRAY® System:

Rapid, Low-Cost Detection of Somatic Variants

Identify Variants as Low as 1% Variant Allele Frequency Without Increasing Costs or DNA Input

Sensitivity Without Sacrifice

In precision oncology testing, several technologies require specimens with high tumor content and generally reject as many as 20% of the samples due to low tumor fraction and DNA yield.

Moreover, many of the currently available technologies have limitations with turnaround times and make poor economic sense:

  • Most NGS platforms can only reliably detect variants down to 5% variant allele frequency (VAF), can be expensive and time-consuming to validate, and require extensive bioinformatics support.
  • Sanger and pyrosequencing can become very challenging at low VAF levels and are unsuitable for high sample volumes.
lung-cancer-tumor-230x230-01

Agena Bioscience’s iPLEX® HS and UltraSEEK® chemistries are optimized to overcome these challenges. Our panels cover large number of variants across multiple genes, providing required coverage at a low cost.

Get Started Now

The MassARRAY® System

With the MassARRAY System’s single-day workflow and multiplexed chemistry, you can get information for clinically informative variants quickly and at a low cost. The high sensitivity of the iPLEX HS chemistry enables detection of clinically relevant variants as low as 1% variant allele frequency from low sample input.

Key Features of Our Targeted Assays:

  • FAST TURNAROUND - Generate results in as quickly as a day
  • COST-EFFECTIVE - Achieve savings as high as 30% with workflow efficiency
  • ACCURATE - Identify Variants as low as 1% Variant Allele Frequency

Get started by completing the online form and we will respond within 24 hours to understand your needs.

MassARRAY System

Additional Resources

Explore our tumor profiling panels
Explore Panels
Create custom assays built for your needs
Learn More
Watch an overview of the MassARRAY System
Watch Video

About Agena Bioscience

At Agena Bioscience, we are dedicated to advancing the impact of genomics in healthcare and precision medicine. Our highly sensitive and cost-effective platform, the MassARRAY System, provides the capability for targeted genetic assays that satisfy the rigorous demands of genomic testing laboratories.

Connect

With exception of the MassARRAY Dx and MassARRAY SARS-CoV-2 Panel, all other products are For Research Use Only. Not for use in diagnostic procedures.
© 2021 Agena Bioscience